Strain Information | |
---|---|
Image | |
BRC No. | RBRC11333 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | LPCAT2 (loxP) (Acc.No.CDB0649K) |
Former Common name | LPCAT2(loxP)(Acc.No.CDB0649K) |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop. Hideo Shindou, Seiji Shiraishi, Suzumi M Tokuoka, Yoshikazu Takahashi, Takeshi Harayama, Takaya Abe, Kana Bando, Kanako Miyano, Yoshihiro Kita, Yasuhito Uezono, Takao Shimizu FASEB J., 31(7):2973-2980 (2017). 28341636 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 8 | Frt | ||||
Lpcat2 MGI:3606214 | lysophosphatidylcholine acyltransferase 2 | 8 | Lpcat2<tm1.1Tksh> MGI:6343500 | targeted mutation 1.1, Takao Shimizu | |||
loxP | phage P1 loxP | 8 | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | loxP:P1ファージ由来、frt:酵母菌由来 |
Research application | Cre/loxP system FLP/frt system |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. FASEB J., 31(7):2973-2980 (2017).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is restricted to a RECIPIENT of a not-for organization for a not-for-profit research. The RECIPIENT shall obtain a prior agreement from the DEVELOPER(Takao Shimizu tshimizu@m.u-tokyo.ac.jp) to transfer the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit organization or by a not-for profit organization for a for-profit research, the RECIPIENT must reach agreement on Terms and Conditions of use of it with the DEPOSITOR (mutant.bdr@riken.jp) and must obtain a prior written consent from the DEPOSITOR. Please inform the DEPOSITOR about the paper when published. |
Depositor | Hiroshi Kiyonari (RIKEN BDR) |
Strain Status | ![]() |
Strain Availability | ![]() |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |